Cornerstone Planning Group LLC Aclaris Therapeutics, Inc. Transaction History
Cornerstone Planning Group LLC
- $322 Billion
- Q1 2024
A detailed history of Cornerstone Planning Group LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 580 shares of ACRS stock, worth $771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
580Holding current value
$771% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.2MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$12.5 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$6.92 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$6.56 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$4.37 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$4.35 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $88.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...